F4 Champions · Season 1
You're researching investors. We want to see what you're building.
Join the open accelerator where your standing changes with what you ship. Enrollment closes August 2.
F4 Champions · Season 1
You're researching investors. We want to see what you're building.
Join the open accelerator where your standing changes with what you ship. Enrollment closes August 2.
7 VC firms investing in biotech & life sciences and manufacturing & industrial at the Growth stage.
F4 Fund tracks 7 VC firms that actively invest in biotech & life sciences + manufacturing & industrial at the Growth stage, with check sizes ranging from $250K – $100000M (median: $50.5M – $50.5M). As of July 2026, and 100% lead or co-lead rounds. Rankings are based on F4's proprietary analysis of 1,539+ researched VC firms, scored by data completeness, portfolio depth, investment recency, and stage alignment.
| # | Firm | Check Size | Portfolio | Leads? | Activity | Decision | Intro |
|---|---|---|---|---|---|---|---|
| 1 | ▶ Initialized Capital Passion and vision matter more than pedigree. We seek founders with grit, audacity, and a spark of rebellion—regardless of background. We invest early, before success is inevitable, and support founders from 0-to-1 through Series A. San Francisco | $250K – $2M | 185 | Leads | Active | ~2 wks | Open |
| 2 | ▶ BGF BGF provides patient, minority growth capital to ambitious SMEs and deep tech/life sciences startups across the UK and Ireland. Founded to address the SME funding gap, BGF never takes controlling stakes, provides long-term support without fixed exit deadlines, and offers portfolio access to its talent network, operating specialists, and community platform. London | $3.8M – $38M | 22 | Both | Active | ~2 mo | Open |
| 3 | ▶ NVIDIA Expand the AI ecosystem by backing technology visionaries solving complex problems to reshape our world. Focus on game changers and market makers in AI, robotics, biotech, autonomous vehicles, and applied AI. Leverage NVIDIA's unique position as GPU infrastructure leader to identify and support companies that will drive adoption of NVIDIA technology. | $20M – $100000M | 37 | Both | Active | ~2 wks | Open |
| 4 | ▶ SpeedInvest Backs globally ambitious technology companies from pre-seed and seed through selected growth rounds using specialist EMEA sector teams and a platform model for capital, customers, talent, follow-on investors, and operational support. Vienna | $250K – $30M | 49 | Leads | Active | N/A | Open |
| 5 | ▶ Battery Ventures Battery Ventures operates as a stage-agnostic firm backing technology-driven category leaders across all growth stages from seed to buyout. The firm believes the best tech investments span the entire founder journey, and they practice collaborative, research-focused investing with embedded operational support through their Portfolio Services platform. They seek technical founders with deep domain expertise and experienced operators building in four core sectors: Application Software, Infrastructure Software, Consumer, and Industrial Tech + Life Science Tools. Boston | $1M – $500M | 23 | Both | Active | ~2 wks | Open |
| 6 | ▶ IDG Capital Backing founders and teams building lasting companies across TMT, healthcare, consumer & entertainment, and advanced manufacturing/clean tech, with a multi-decade time horizon and a bridge role between China and global capital markets. Hong Kong | $1M – $100M | 23 | Both | Active | ~2 mo | Req'd |
| 7 | ▶ Cathay Innovation Startups positioned as transformation partners with Fortune 500 corporates create the most impactful solutions. We believe the next generation of market leaders will emerge through collaborative innovation between startups and incumbent enterprises, supported by global expertise and capital. Paris | $5M – $100M | 16 | Both | Active | ~1 mo | Req'd |
What other stages do these firms also invest in?
Investors on this page also frequently invest in these sectors
What other sectors do these firms also invest in?
F4 Fund tracks 7 VC firms that actively invest in biotech & life sciences + manufacturing & industrial at the Growth stage. These firms are ranked using a composite score that weighs data completeness (30%), portfolio depth (30%), investment recency (25%), and stage alignment (15%).
Based on F4's analysis, the median check size for growth biotech & life sciences + manufacturing & industrial investors is $50.5M – $50.5M, with a full range from $250K – $100000M. The distribution breaks down as: 1 firms in the $1M-$2M range, 6 firms in the $10M+ range.
Among the 7 firms tracked, 100% lead or co-lead rounds. Founders seeking a lead investor should filter for firms marked "Leads" or "Both" in the rankings table above. Lead investors typically set deal terms and anchor the round.
The best growth biotech & life sciences + manufacturing & industrial investors combine domain expertise with an active portfolio in the space. Among these firms, 29% prefer warm introductions, and the average firm has 51 portfolio companies. Look for firms whose check size matches your raise, whose stage preference aligns with yours, and who have a track record of supporting companies in your sector through multiple growth phases.
Firm profiles are continuously updated through F4's research pipeline, which combines LLM-powered web research, portfolio analysis, and transcript extraction. The ranking data refreshes every 12 hours. Editorial analysis is reviewed weekly. Individual firm profiles are re-researched on a 30-day cycle or when new information surfaces.